Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.
Avni Gupta, BDS, MPH
Advertisement
Articles by Avni Gupta, BDS, MPH
Advertisement
Latest Updated Articles
- Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask
Published: October 14th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
2
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
3
3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission
4
Real-World Evidence Supports Switch to Next-Generation BTK Inhibitor for CLL: A Q&A With Margaret Krackeler, MD
5